Citigroup’s abrdn Healthcare Investors HQH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.53K | Buy |
311
+18
| +6% | +$340 | ﹤0.01% | 5237 |
|
|
2025
Q4 | $5.55K | Hold |
293
| – | – | ﹤0.01% | 5215 |
|
|
2025
Q3 | $5.41K | Buy |
+293
| New | +$4.79K | ﹤0.01% | 5211 |
|
|
2021
Q3 | – | Sell |
-39
| Closed | -$1K | – | 6015 |
|
|
2021
Q2 | $1K | Sell |
39
-6
| -13% | -$148 | ﹤0.01% | 6037 |
|
|
2021
Q1 | $1K | Buy |
45
+6
| +15% | +$146 | ﹤0.01% | 6102 |
|
|
2020
Q4 | $1K | Hold |
39
| – | – | ﹤0.01% | 7284 |
|
|
2020
Q3 | $1K | Sell |
39
-2,063
| -98% | -$43.6K | ﹤0.01% | 7370 |
|
|
2020
Q2 | $45K | Hold |
2,102
| – | – | ﹤0.01% | 6083 |
|
|
2020
Q1 | $37K | Buy |
2,102
+2,064
| +5,432% | +$40.7K | ﹤0.01% | 6240 |
|
|
2019
Q4 | $1K | Hold |
38
| – | – | ﹤0.01% | 7598 |
|
|
2019
Q3 | $1K | Sell |
38
-20
| -34% | -$385 | ﹤0.01% | 7613 |
|
|
2019
Q2 | $1K | Buy |
58
+20
| +53% | +$395 | ﹤0.01% | 7675 |
|
|
2019
Q1 | $1K | Hold |
38
| – | – | ﹤0.01% | 7581 |
|
|
2018
Q4 | $1K | Buy |
38
+1
| +3% | +$20 | ﹤0.01% | 7573 |
|
|
2018
Q3 | $1K | Buy |
+37
| New | +$838 | ﹤0.01% | 7662 |
|
|
2018
Q2 | – | Sell |
-32
| Closed | -$1K | – | 7652 |
|
|
2018
Q1 | $1K | Hold |
32
| – | – | ﹤0.01% | 7442 |
|
|
2017
Q4 | $1K | Sell |
32
-1,350
| -98% | -$31.6K | ﹤0.01% | 7476 |
|
|
2017
Q3 | $35K | Buy |
1,382
+1,381
| +138,100% | +$34.7K | ﹤0.01% | 6170 |
|
|
2017
Q2 | $0 | Sell |
1
-80
| -99% | -$1.98K | ﹤0.01% | 7401 |
|
|
2017
Q1 | $2K | Sell |
81
-96,221
| -100% | -$2.26M | ﹤0.01% | 6996 |
|
|
2016
Q4 | $2.04M | Buy |
96,302
+53,409
| +125% | +$1.19M | ﹤0.01% | 2922 |
|
|
2016
Q3 | $1.02M | Buy |
42,893
+38,702
| +923% | +$973K | ﹤0.01% | 3193 |
|
|
2016
Q2 | $98K | Sell |
4,191
-68,534
| -94% | -$1.7M | ﹤0.01% | 5091 |
|
|
2016
Q1 | $1.75M | Buy |
72,725
+29,010
| +66% | +$690K | ﹤0.01% | 2663 |
|
|
2015
Q4 | $1.3M | Sell |
43,715
-1,504
| -3% | -$46.4K | ﹤0.01% | 2853 |
|
|
2015
Q3 | $1.25M | Buy |
45,219
+39,111
| +640% | +$1.33M | ﹤0.01% | 2867 |
|
|
2015
Q2 | $213K | Buy |
6,108
+132
| +2% | +$4.58K | ﹤0.01% | 4393 |
|
|
2015
Q1 | $204K | Sell |
5,976
-510
| -8% | -$17.1K | ﹤0.01% | 4509 |
|
|
2014
Q4 | $200K | Buy |
6,486
+4,327
| +200% | +$130K | ﹤0.01% | 4687 |
|
|
2014
Q3 | $60K | Buy |
2,159
+2,085
| +2,818% | +$56.5K | ﹤0.01% | 5166 |
|
|
2014
Q2 | $2K | Sell |
74
-153
| -67% | -$3.98K | ﹤0.01% | 6745 |
|
|
2014
Q1 | $6K | Buy |
227
+208
| +1,095% | +$5.78K | ﹤0.01% | 6543 |
|
|
2013
Q4 | $1K | Sell |
19
-10
| -34% | -$245 | ﹤0.01% | 6858 |
|
|
2013
Q3 | $1K | Buy |
29
+10
| +53% | +$236 | ﹤0.01% | 6670 |
|
|
2013
Q2 | $0 | Buy |
+19
| New | +$404 | ﹤0.01% | 6764 |
|
Other funds holding HQH
PCM
AAM
NIM
ZCP
Citigroup's HQH Position: Q1 2026 in Review
Citigroup increased its abrdn Healthcare Investors (HQH) stake by 6.1% in Q1 2026, buying an estimated $340 and bringing the position to 311 shares worth $5.53K. The position accounts for ﹤0.01% of the portfolio, ranked #5237.
Citigroup first reported a position in HQH in Q2 2013 and has held it in 35 quarters since. The position peaked at $2.04M in Q4 2016. 128 funds tracked by Wall St. Rank hold HQH as of Q1 2026.
- Citigroup held 311 shares of abrdn Healthcare Investors worth $5.53K as of Q1 2026.
- Citigroup bought 18 abrdn Healthcare Investors shares in Q1 2026, an estimated $340.
- abrdn Healthcare Investors made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5237 holding.
- Citigroup first reported a position in abrdn Healthcare Investors in Q2 2013 and has held it in 35 quarters since.
- Citigroup's abrdn Healthcare Investors position peaked at $2.04M in Q4 2016.
- 128 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.